Europe Biotechnology Market Summary, Competitive Analysis and Forecast to 2027

Europe Biotechnology Market Summary, Competitive Analysis and Forecast to 2027
Summary
Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key HighlightsThe biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.The European biotechnology market had total revenues of $249.9 billion in 2022, representing a compound annual growth rate (CAGR) of 11.3% between 2017 and 2022.Medical/healthcare segment accounted for market's the largest proportion in 2022, with total revenues of $176.1 billion, equivalent to 70.5% of the market's overall value.The UK held the largest share in the European biotechnology market, accounting for 54.9% share in 2022. The market is growing as a result of factors such as supportive government policies, the introduction of new and cutting-edge products, significant investment in the biotechnology industry, and rising demand for new and innovative goods.ScopeSave time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in EuropeUse the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in EuropeLeading company profiles reveal details of key biotechnology market players’ global operations and financial performanceAdd weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecastsReasons to BuyWhat was the size of the Europe biotechnology market by value in 2022?What will be the size of the Europe biotechnology market in 2027?What factors are affecting the strength of competition in the Europe biotechnology market?How has the market performed over the last five years?Who are the top competitors in Europe's biotechnology market?